Search Results - "El‐berri, Eman I."

The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer’s Disease-like Condition: Mechanistic Insights by Abo Mansour, Hend E, Elberri, Aya Ibrahim, Ghoneim, Mai El-Sayed, Samman, Waad A, Alhaddad, Aisha A, Abdallah, Mahmoud S, El-Berri, Eman I, Salem, Mohamed A, Mosalam, Esraa M

“…Background: Alzheimer’s disease (AD) is a common neurodegenerative disorder without effective treatment. Thymoquinone (TQ) has demonstrated potential in…”
Get full text

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial by El-Khateeb, Eman, El-Berri, Eman I, Mosalam, Esraa M, Nooh, Mohamed Z, Abdelsattar, Shimaa, Alghamdi, Amira M, Alrubia, Sarah, Abdallah, Mahmoud S

“…Type 2 diabetes mellitus (T2DM) is common with obesity. Metformin is a first-line therapy for this condition. However, it has only a minor impact on weight…”
Get full text

Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial by Abdallah, Mahmoud S., Mosalam, Esraa M., Hassan, Ahmed, Ramadan, Ahmed N., Omara‐Reda, Hend, Zidan, Abdel‐Aziz A., Samman, Waad A., El‐berri, Eman I.

“…Aim The aim of this study was to explore the effectiveness and safety of pentoxifylline as an adjuvant to risperidone in mitigating the negative symptoms in…”
Get full text

Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma by Hegazy, Sahar K., El-Haggar, Sahar M., Alhassanin, Suzan A., El-berri, Eman I.

“…The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for…”
Get full text

RETRACTED: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial by Abdallah, Mahmoud S., Mosalam, Esraa M., Hassan, Ahmed, Ramadan, Ahmed N., Omara‐Reda, Hend, Zidan, Abdel‐Aziz A., Samman, Waad A., El‐berri, Eman I.

“…AimThe aim of this study was to explore the effectiveness and safety of pentoxifylline as an adjuvant to risperidone in mitigating the negative symptoms in…”
Get full text